This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Ju Huang - Innovator in Neurodegenerative Disease Treatment
Introduction
Ju Huang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of neurodegenerative diseases through his innovative research and patents. His work focuses on developing solutions for conditions such as Alzheimer's disease, Huntington's disease, and Parkinson's disease.
Latest Patents
Ju Huang holds a patent for a tetradentate chelating monoquinoline derivative. This derivative is designed to specifically chelate redox active metal ions, particularly copper ions, which are often dysregulated in various neurodegenerative diseases. The patent outlines a manufacturing method for this derivative and its application as a metal ion regulator. The binding constants of these derivatives for zinc are significantly lower than those for copper, indicating their specificity. Additionally, these derivatives demonstrate a strong capability to reduce oxidative stress, making them promising candidates for drug development in treating neurodegenerative diseases and disorders related to copper metabolism. He has 1 patent to his name.
Career Highlights
Throughout his career, Ju Huang has worked at Guangdong University of Technology, where he has contributed to research and development in his field. His innovative approach has garnered attention and respect within the scientific community.
Collaborations
Ju Huang has collaborated with notable colleagues, including Yan Liu and Xingguo Liu, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Ju Huang's contributions to the field of neurodegenerative diseases through his innovative patent highlight the importance of research in developing effective treatments. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile